Serum GDF-15 level in Behcet's disease: relationships between disease activity and clinical parameters

dc.contributor.authorSariyildiz, Mustafa Akif
dc.contributor.authorYazmalar, Levent
dc.contributor.authorBatmaz, Ibrahim
dc.contributor.authorAlpayci, Mahmut
dc.contributor.authorBurkan, Yahya Kemal
dc.contributor.authorSula, Bilal
dc.contributor.authorKaplan, Ibrahim
dc.date.accessioned2024-04-24T17:11:28Z
dc.date.available2024-04-24T17:11:28Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description.abstractGrowth differentiation factor-15 (GDF-15), a member of the transforming growth factor-b superfamily of cytokines, plays an important role in cell growth, signal transduction, and apoptosis regulation. The aim of this study was to evaluate serum GDF-15 levels and their relationships with disease-related variables in patients with Behcet's disease (BD). Fortysix patients diagnosed with BD and 30 demographically matched healthy control subjects participated in the study. GDF-15 levels were measured in blood samples from patients and controls. The Behcet's Disease Current Activity Form (BDCAF) was used to evaluate the disease activity of BD. There were no significant differences between the two groups in C-reactive protein (CRP) level, mean erythrocyte sedimentation rate (ESR), age, body mass index, and mean GDF-15 levels (P > 0.05). Serum GDF-15 levels were positively correlated with findings for peripheral arthritis and CRP, and with BDCAF erythema nodosum, BDCAF arthralgia, and BDCAF arthritis scores. Patients with BD were divided into two groups according to the presence of peripheral arthritis; nine subjects (20%) were positive for peripheral arthritis. Serum ESR, CRP, white blood cell counts, and GDF-15 levels were significantly higher in the group that was positive for peripheral arthritis (P < 0.05). GDF-15 may play a role in the progression and pathway of Behcet's joint involvement and erythema nodosum that is independent of classic inflammatory response measures.en_US
dc.identifier.doi10.1111/ijd.13309
dc.identifier.endpage1294en_US
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue11en_US
dc.identifier.pmid27206990
dc.identifier.scopus2-s2.0-84989892028
dc.identifier.scopusqualityQ1
dc.identifier.startpage1289en_US
dc.identifier.urihttps://doi.org/10.1111/ijd.13309
dc.identifier.urihttps://hdl.handle.net/11468/17543
dc.identifier.volume55en_US
dc.identifier.wosWOS:000385763500032
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleSerum GDF-15 level in Behcet's disease: relationships between disease activity and clinical parametersen_US
dc.titleSerum GDF-15 level in Behcet's disease: relationships between disease activity and clinical parameters
dc.typeArticleen_US

Dosyalar